Further investigation revealed that suppression of PRKCSH led to G2/M cell cycle arrest of lung cancer cells treated with Nano ZnO, which hypothesized to mediate through the translocation of STAT6 to nucleus and activate p53 (24). The gene discussed is PRKCSH; the disease is lung cancer.